Cipher Pharmaceuticals, Inc. (CPH.TO)
14.25
+0.09
(+0.64%)
CAD |
TSX |
Aug 26, 10:28
Cipher Pharmaceuticals Debt to Equity Ratio : 0.0027 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0027 |
| March 31, 2026 | 0.0032 |
| December 31, 2025 | 0.0436 |
| September 30, 2025 | 0.1175 |
| June 30, 2025 | 0.2326 |
| March 31, 2025 | 0.3849 |
| December 31, 2024 | 0.3965 |
| September 30, 2024 | 0.4122 |
| June 30, 2024 | 0.0033 |
| March 31, 2024 | 0.0038 |
| December 31, 2023 | 0.0044 |
| September 30, 2023 | 0.0046 |
| June 30, 2023 | 0.0055 |
| March 31, 2023 | 0.006 |
| December 31, 2022 | 0.0067 |
| September 30, 2022 | 0.01 |
| June 30, 2022 | 0.0121 |
| March 31, 2022 | 0.013 |
| December 31, 2021 | 0.0133 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0516 |
| March 31, 2021 | 0.0543 |
| December 31, 2020 | 0.0566 |
| September 30, 2020 | 0.1055 |
| June 30, 2020 | 0.1745 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2408 |
| December 31, 2019 | 0.3416 |
| September 30, 2019 | 0.5112 |
| June 30, 2019 | 0.6234 |
| March 31, 2019 | 0.7317 |
| December 31, 2018 | 0.7182 |
| September 30, 2018 | 0.7595 |
| June 30, 2018 | 0.8703 |
| March 31, 2018 | 0.74 |
| December 31, 2017 | 0.7826 |
| September 30, 2017 | 1.036 |
| June 30, 2017 | 1.219 |
| March 31, 2017 | 2.598 |
| December 31, 2016 | 2.027 |
| September 30, 2016 | 1.224 |
| June 30, 2016 | 0.7022 |
| March 31, 2016 | 0.6635 |
| December 31, 2015 | 0.6373 |
| September 30, 2015 | 0.6662 |
| June 30, 2015 | 0.64 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| HLS Therapeutics, Inc. | 0.7586 |
| Bausch Health Cos., Inc. | -11.73 |
| BioSyent, Inc. | 0.0685 |
| Revive Therapeutics Ltd. | -0.0176 |
| Knight Therapeutics, Inc. | 0.0429 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 222.59M |
| Total Liabilities (Quarterly) | 27.86M |
| Shareholders Equity (Quarterly) | 194.73M |
| Current Ratio | 1.588 |
| Net Debt Paydown Yield | 2.73% |